FDA approves Boston Scientific's market-first wire-free pacemaker

October 1, 2012 by MassDevice staff

Medical device titan Boston Scientific lands FDA approval for the subcutaneous lead-free heart rhythm implant it acquired in the $1.35 billion deal for Cameron Health.

Cameron Health's subcutaneous ICD

Boston Scientific (NYSE:BSX) and newly acquired Cameron Health won FDA approval for the world's only commercially available lead-free implantable cardioverter defibrillator, the S-ICD.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.